FUTUREMAP PTE. LTD. – Trademark Portfolio

Entity Type: 99

FUTUREMAP PTE. LTD. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 5 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include FUTUREMAP and CLIMATE OASES.

101 UPPER CROSS STREET,

#05-16 PEOPLE'S PARK CENTRE Singapore 05

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

FUTUREMAP PTE. LTD.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

36
Insurance & Financial (5 filings)

Insurance; financial affairs; monetary affairs; real estate affairs

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does FUTUREMAP PTE. LTD. have?

FUTUREMAP PTE. LTD. has 6 U.S. trademarks filed with the USPTO. Of these, 2 registered, 4 abandoned.

What trademark classes does FUTUREMAP PTE. LTD. file in?

FUTUREMAP PTE. LTD. files trademarks across 2 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 9 (Computers & Electronics). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.

What are FUTUREMAP PTE. LTD.'s most well-known trademarks?

FUTUREMAP PTE. LTD.'s registered trademark portfolio includes well-known marks such as FUTUREMAP and CLIMATE OASES. These are among 2 currently registered trademarks in the portfolio.

What is FUTUREMAP PTE. LTD.'s trademark registration success rate?

FUTUREMAP PTE. LTD. has a 33% trademark registration rate, with 2 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.